Targeting and Specific Activation of Antigen‐Presenting Cells by Endogenous Antigen‐Loaded Nanoparticles Elicits Tumor‐Specific Immunity

Immunotherapy has shown tremendous promise for improving cancer treatment. Unfortunately, antigen‐presenting cells (APCs) in cancer patients cannot effectively recognize and process tumor antigens to activate host immune responses. In this study, an approach is developed to improve cancer immunother...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hao‐Cai, Zou, Zheng‐Zhi, Wang, Qiu‐Hong, Li, Jie, Jin, Huan, Yin, Qian‐Xia, Xing, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947714/
https://www.ncbi.nlm.nih.gov/pubmed/31921548
http://dx.doi.org/10.1002/advs.201900069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947714/
https://www.ncbi.nlm.nih.gov/pubmed/31921548
http://dx.doi.org/10.1002/advs.201900069

Ejemplares similares